Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The human antibody response to influenza A virus infection and vaccination
Florian Krammer
Nature reviews. Immunology (2019) Vol. 19, Iss. 6, pp. 383-397
Open Access | Times Cited: 641

Showing 26-50 of 641 citing articles:

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 91
Original Antigenic Sin: How Original? How Sinful?
Jonathan W. Yewdell, Jefferson Santos
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 5, pp. a038786-a038786
Open Access | Times Cited: 90
Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
Hannah E. Maier, Raffael Nachbagauer, Guillermina Kuan, et al.
Clinical Infectious Diseases (2019) Vol. 70, Iss. 11, pp. 2290-2297
Open Access | Times Cited: 88
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Angelika Wagner, Birgit Weinberger
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 86
Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 84
Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
Cynthia Calzas, Christophe Chevalier
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 78
Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
Jéromine Klingler, Svenja Weiß, Vincenza Itri, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 6, pp. 957-970
Open Access | Times Cited: 78
Are we underestimating seroprevalence of SARS-CoV-2?
Stephen Burgess, Mark Ponsford, Dipender Gill
BMJ (2020), pp. m3364-m3364
Open Access | Times Cited: 76
Development of vaccine formulations: past, present, and future
Carmine D’Amico, Flavia Fontana, Ruoyu Cheng, et al.
Drug Delivery and Translational Research (2021) Vol. 11, Iss. 2, pp. 353-372
Open Access | Times Cited: 75
Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection
Kayla Frank, Silke Paust
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 72
COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review
Jessica Jones, Aiman Faruqi, James Sullivan, et al.
Pathogens and Immunity (2021) Vol. 6, Iss. 1, pp. 76-103
Open Access | Times Cited: 72
Influenza vaccination: protecting the most vulnerable
Alex R Tanner, Robert B. Dorey, Nathan J. Brendish, et al.
European Respiratory Review (2021) Vol. 30, Iss. 159, pp. 200258-200258
Open Access | Times Cited: 69
Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract
Edin Mifsud, Miku Kuba, Ian Barr
Viruses (2021) Vol. 13, Iss. 10, pp. 2090-2090
Open Access | Times Cited: 68
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
Claudia Maria Trombetta, Otfried Kistner, Emanuele Montomoli, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 714-714
Open Access | Times Cited: 65
Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
Alexander A. Cohen, Zhi Yang, Priyanthi N.P. Gnanapragasam, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247963-e0247963
Open Access | Times Cited: 62
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin S. Herati, David A. Knorr, Laura A. Vella, et al.
Nature Immunology (2022) Vol. 23, Iss. 8, pp. 1183-1192
Open Access | Times Cited: 62
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 61
Electrochemical Biosensors for the Detection of SARS-CoV-2 and Other Viruses
Saim Imran, Soha Ahmadi, Kağan Kerman
Micromachines (2021) Vol. 12, Iss. 2, pp. 174-174
Open Access | Times Cited: 59
Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains
Chunhong Dong, Ye Wang, Gilbert X. Gonzalez, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 59
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Yanyun Du, Rui Shi, Ying Zhang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59
BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2
R. Camille Brewer, Nitya S. Ramadoss, Lauren J. Lahey, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 33-39
Open Access | Times Cited: 57
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 55
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids
Jenna M. Kastenschmidt, Suhas Sureshchandra, Aarti Jain, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1910-1926.e7
Open Access | Times Cited: 43
Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology
Robert C. Mettelman, Aisha Souquette, Lee-Ann Van de Velde, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1511-1526
Open Access | Times Cited: 38

Scroll to top